Vimarsana
Biggest News Aggregation in the World

Page 8 - Fda Approval News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Fda Approval. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Fda Approval Today - Breaking & Trending Today

The Evolving Role of Surgery in the Management of Desmoid Tumors - Vimarsana News

The Evolving Role of Surgery in the Management of Desmoid Tumors

Chandrajit Raut, MD, shares expert insights into the evolving role of surgical strategies for desmoid tumor management, emphasizing essential factors in patient selection.

Treatment Strategies Using Radiotherapy or Other Locoregional Approaches in Desmoid Tumors - Vimarsana News

Treatment Strategies Using Radiotherapy or Other Locoregional Approaches in Desmoid Tumors

Chandrajit Raut, MD, explores the role of radiotherapy and other locoregional strategies in desmoid tumor management, highlighting the emerging role of cryoablation and HIFU.

Gene-editing therapy Lyfgenia and CRISPR therapy Casgevy bring hope for sickle cell anemia patients but high costs pose challenges - Vimarsana News

Gene-editing therapy Lyfgenia and CRISPR therapy Casgevy bring hope for sickle cell anemia patients but high costs pose challenges

FDA-approved Lyfgenia and CRISPR gene editing therapy Casgevy are effective against sickle cell disease, but the high price poses a challenge.

Source: abc7.com
Marine vet touts benefits of psychedelic-assisted PTSD drugs as FDA considers MDMA approval - Vimarsana News

Marine vet touts benefits of psychedelic-assisted PTSD drugs as FDA considers MDMA approval

A drug application for psychedelic-assisted therapies has been filed for FDA approval. Marine Corps veteran Juliana Mercer shares the benefits of the treatment, with doctors also weighing in.

Source: yahoo.com
FDA Approves Balversa for Metastatic Bladder Cancer - Vimarsana News

FDA Approves Balversa for Metastatic Bladder Cancer

The FDA amended its approval for Balversa for the treatment of patients with locally advanced or metastatic bladder cancer.